Acetylshikonin suppresses diffuse large B-Cell Lymphoma cell growth by targeting the T-lymphokine-activated killer cell-originated protein kinase signalling pathway

Diffuse large B-cell lymphoma (DLBCL) is one of the most common causes of cancer death worldwide, and responds poorly to the existing treatments. Thus, identifying novel therapeutic targets of DLBCL is urgently needed. In this study, we found that T-lymphokine-activated killer cell-originated protei...

Descripción completa

Detalles Bibliográficos
Autores principales: Cui, Jieke, Guo, Rong, Wang, Yingjun, Song, Yue, Song, Xuewen, Li, Hongwen, Song, Xiaoqin, Li, Jiwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8973784/
https://www.ncbi.nlm.nih.gov/pubmed/35139768
http://dx.doi.org/10.1080/21655979.2022.2034584

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8973784/
https://www.ncbi.nlm.nih.gov/pubmed/35139768
http://dx.doi.org/10.1080/21655979.2022.2034584

Ejemplares similares